We are live on ! Find out more

VanEck Pharmaceutical ETF

PPH

Market cap $1.06B

114.63 USD

-0.16

0.14%

At close Updated Oct 27, 4:00 PM EDT

Pre-market

After hours

114.21

-0.42

0.37%

1 day

-0.14%

5 days

-0.81%

1 month

2.83%

3 months

2.98%

6 months

15.29%

Year to date

10.52%

1 year

23.86%

5 years

56.15%

10 years

109.83%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 10%

Neutral 80%

Negative 10%

The Motley Fool

Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?

Simplify Health Care ETF has a higher expense ratio and a lower dividend yield than VanEck Pharmaceutical ETF. VanEck Pharmaceutical ETF maintains a more concentrated portfolio focused exclusively on global pharmaceutical giants.

Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?

Zacks Investment Research

Execution of Pharma Tariffs Brings These ETFs Into Focus

Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.

Execution of Pharma Tariffs Brings These ETFs Into Focus

Zacks Investment Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on December 20, 2011.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

The Motley Fool

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP

The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP

The Motley Fool

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.

The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a significantly higher dividend yield and a lower expense ratio than its counterpart.

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.

Zacks Investment Research

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Zacks Investment Research

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

The Motley Fool

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad exposure across the healthcare sector, whereas the VanEck Pharmaceutical ETF (NYSEMKT:PPH) concentrates specifically on pharmaceutical stocks. PPH offers a slightly lower expense ratio and a higher dividend yield than IYH.

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

The Motley Fool

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

VanEck Pharmaceutical ETF features a lower expense ratio of 0.36% compared to 0.58% for Invesco Biotechnology & Genome ETF. Invesco Biotechnology & Genome ETF delivered a higher 1-year total return of 47.3% but experienced a significantly deeper maximum drawdown of 34.7%.

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

Zacks Investment Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Launched on December 20, 2011, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

See News Rankings

Price charts implemented using Lightweight Charts™